Verona Pharma has claimed FDA approval for its ... killing more than three million people in 2019, according to World Health Organization (WHO) estimates. The massive number of patients with ...

We recently published a list of 10 Best Multibagger Stocks to Buy According to Billionaires. In this article, we are going to ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine, its ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $65.0 for Verona Pharma, spanning the last three ...

In the pre-market hours, Verona's stock is trading at $65.79 ... RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages ...

Ohtuvayre's robust launch for COPD treatment exceeded expectations, with Q4 revenue of $36.6 million and FY24 revenue of $42.3 million, indicating strong market demand. Verona's financial health ...